Isolagen Facial Wrinkle BLA Filing Slated For First Quarter 2005
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Isolagen plans to submit a BLA for use of its autologous cellular collagen process for treatment of facial wrinkles "as early as the first quarter of 2005."